• Scout AI

  Participated · Seed · Apr 2025

  Scout AI develops vision-language-action-based AI models and command-and-control software for military autonomous vehicles and drones. Its flagship model effort, "Fury," is being trained to operate and command assets for logistical missions and, in time, weaponized systems; the company also projects a command product called "Ox" for soldier-facing orchestration of multiple platforms. Scout conducts real-world training at a range it calls Foundry on a U.S. military base, using ATVs and drones to generate reinforcement learning data and to test agents in challenging off-road conditions. The startup participates in Army experiments—its technology is among vendors used by the 1st Cavalry Division—and has active contracts with DARPA and the Army Applications Laboratory. Scout says it currently builds on pretrained models from major hyperscalers while planning to invest its capital in training and compute to develop its own foundation models.

• nZero

  Participated · Series A · Apr 2023

  nZero, led by CEO Adam Kramer and based in Reno, NV, offers a near real-time carbon management and accounting platform that automatically syncs, analyzes, and manages emissions data. The system pairs financial and emissions data to deliver hour-by-hour tracking and granular insights across Scopes 1, 2 and 3, enabling clients to track, manage, and report sustainability goals. nZero emphasizes continuous 24/7 monitoring to capture emissions changes and inform financially efficient reduction plans. Since launching services in April 2021, the company has worked with corporate, agriculture, and government entities globally. The company intends to use recent funding to scale its platform internationally and expand its customer base.

• Tavros Therapeutics

  Led · Seed · Sep 2022

  Tavros Therapeutics develops a bi-directional synthetic lethality platform that combines functional and computational genomics to identify paired genetic interactions underlying tumor vulnerabilities. The platform is used to discover novel, de-risked, druggable targets and to clinically position existing and new molecules with biomarker-driven strategies. Tavros aims to improve patient outcomes, minimize toxicity, and speed development in defined patient subsets by accelerating target discovery and validation. The company has a strategic partnership with Zentalis Pharmaceuticals that has validated the platform and expanded its clinical impact. Tavros is also using its synthetic lethal relationship map to build a pipeline of category-defining small-molecule drug candidates. Led by CEO Eoin McDonnell, the company intends to use recent funding to continue developing its proprietary platform.

• Epirus

  Participated · Series C · Feb 2022

  Epirus develops counter-drone systems centered on its Leonidas platform, which beams high-powered electromagnetic pulses at drones as it moves across the battlefield. The company has won multiple U.S. military contracts, including a $66 million Army deal awarded in 2023. Epirus plans to use new funding to expand into international and commercial markets, grow its team, improve supply chain resiliency, and open a simulation center in Oklahoma to train soldiers. Financially, Epirus has raised an oversubscribed $250 million Series D and says its valuation is over $1 billion. The firm was previously valued at $1.35 billion after a $200 million Series C in 2022, and Bloomberg reported the new round was being raised at a lower valuation than that Series C. To date, Epirus has raised more than $550 million in total. Epirus designs solid‑state, software‑defined directed energy systems and a machine‑intelligent SmartPower platform to optimize power efficiency in defense and commercial applications. Its flagship Leonidas high‑power microwave (HPM) system and the portable Leonidas Pod create a layered counter‑electronics capability against hostile drones and electronic threats. The company has multiple product lines in development and says recent DARPA and Army Applications Laboratory contracts validate its defense market traction. In the past year Epirus more than doubled its workforce and opened a Corporate Headquarters in Torrance, California to support accelerated growth. Founded in 2018, Epirus emphasizes rapid innovation and plans to expand its team and commercial applications for its technology. Financially, the company announced a $200 million Series C, bringing total financing to date to $287 million and valuing the business at $1.35 billion. Epirus builds software-defined high-powered microwave (HPM) products and directed-energy systems, with SmartPower power-management technology at the center of its product roadmap. The company is bringing its flagship Leonidas C-UAS system to market in early 2021 and is developing additional directed-energy solutions for defense and commercial markets. Epirus has a strategic supplier agreement with Northrop Grumman to provide an EMP capability as a component of Northrop Grumman’s C-UAS systems-of-systems offering. L3Harris Technologies is partnering with and investing in Epirus to create greater power efficiencies within some of its systems. The company has expanded its footprint with an office in Tysons Corner and plans to hire roughly 100 roles in 2021 and double headcount again in 2022, with further expansion across Los Angeles, Virginia, and the Midwest. Recent financings support its manufacturing and scale-up plans for SmartPower and other products.

No current team members are available.